Delivery Order SPE2DB25D3006-SPE2DB25FXKDS
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $38,677.88 to AmerisourceBergen Drug Corp for the supply of IPOL Vial 5ML pharmaceutical products. This firm fixed-price, competitively awarded delivery order was issued on July 23, 2025, with an ultimate completion date of July 24, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating AmerisourceBergen Drug Corp...
- The Defense Logistics Agency awarded a delivery order valued at $1,652.21 to AmerisourceBergen Drug Corp for IPOL vial 5ML, a poliomyelitis vaccine product. The contract, executed on August 12, 2025, with an ultimate completion date of August 13, 2025, is a firm fixed price delivery order with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award represents a competitive procurement action under an existing contract...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of IPOL Vial 5ML, a poliomyelitis vaccine product. This firm fixed-price delivery order, valued at $1,526.14, represents a non-competitive award and is categorized as a child contract under AmerisourceBergen's larger federal contract vehicle. The order is scheduled for completion by August 19, 2025, with performance at the contractor's location in Conshohocken,...
- The Defense Logistics Agency awarded a $2,307.21 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Ipol Vial 5ML, a polio vaccine product. This firm fixed-price, non-set-aside contract is scheduled for completion by August 20, 2025, with performance at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a pediatric immunization pharmaceutical requirement within the federal medical supply chain. This award is...
- The Defense Logistics Agency Troop Support Medical awarded a $273,510 firm fixed price delivery order to Amerisourcebergen Drug Corporation for IPOL vials. The order is for 4561322355 5mL vials of IPOL to be delivered to Amerisourcebergen's facility in Conshohocken, Pennsylvania by June 26, 2023. Amerisourcebergen will provide the vials in support of the Defense Logistics Agency's medical supply chain initiatives. No subcontractors or set aside designations were identified. The delivery order...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of IPOL Vial 5ML, a polio vaccine product. This competitively awarded, non-set-aside contract carries a ceiling value of $5,437.76 with firm fixed pricing and an ultimate completion date of August 21, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at ten thousand nine hundred eighty-eight dollars to Amerisourcebergen Drug Corporation for 4561585422 IPOL vials (5ml) to be delivered to their Conshohocken, Pennsylvania facility. Performance will take place between July 24-25, 2023. The Defense Logistics Agency supports Department of Defense health care requirements through its medical supply chain responsibilities, and this order for polio...
- This delivery order, valued at $132,136, was awarded on July 21, 2025, to AmerisourceBergen Drug Corp for supply of Ipol vial 5ML pharmaceutical products. The contract, which is not set-aside and was competitively awarded, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 22, 2025. The Defense Logistics Agency (DLA), which manages the federal medical supply chain, funded this award under firm fixed-price...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,870.10 on August 4, 2025, for the supply of IPOL Vial 5ML pharmaceutical product. The contract is a firm fixed price delivery order with an ultimate completion date of August 5, 2025, and represents a non-set-aside competitive award. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support...
- The Defense Logistics Agency awarded a $79,113.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561373729 IPOL vials (5ml each). The place of performance is Conshohocken, Pennsylvania. The order runs from June 29, 2023 through June 30, 2023. DLA utilizes indefinite-delivery/indefinite-quantity contracts to supply medical materiel to all branches of the U.S. military. This delivery order was placed under one such contract vehicle to procure a specific quantity of...
- SPE2DB25D3006Indefinite Delivery Contract
- SPE2DB25D3006-SPE2DB25FXKDSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,159.48 to AmerisourceBergen Drug Corp for IPOL Vial 5ML on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. IPOL is an inactivated poliovirus vaccine commonly used in federal immunization programs and military healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, supplying a comprehensive range of pharmaceutical products, vaccines, and medical supplies to support military and veteran healthcare systems worldwide. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse medical supply requirements through open competition and its established relationships with the Defense Health Agency and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 8/20/25 |